Sun Pharma slips 3% as outlook disappoints; key levels in focus

Sun Pharma shares fell 3% in Friday trade as management's guidance disappointed the street. Analyst Manish Kushwaha states that Sun Pharma's stock is trading between converging trendlines, with support at ₹1,525 and resistance between ₹1,750 to ₹1,780. A weekly break above this resistance could push the stock towards ₹2,000.